Appendix Adenocarcinoma — Trials

Appendix Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 13%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07753824	A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)	not yet recruiting	Phase 2	30	M.D. Anderson Cancer CenterOTHER	1	Aug 27, 2026	clinicaltrials

Data updated 22 days agoSource updated Aug 27, 2026source: clinicaltrials